Parkinson’s Disease: Biotech Oryon Cell Therapies Raises $21M for Brain Repair Trial
A relatively unknown biotechnology firm, Oryon Cell Therapies, has stepped into the spotlight following a $21 million funding round and the release of early clinical data … Read more